tiprankstipranks
Trending News
More News >

Roche CEO says Trump’s drug pricing order threatens investment, WSJ reports

Roche (RHHBY) CEO Thomas Schinecker says that President Trump’s executive order seeking to tie U.S. drug prices to those abroad could impact future investment in America, The Wall Street Journal’s Jared S. Hopkins reports. The company has planned to invest $50B in the U.S. over the next five years, and when asked how the order, signed last month and opposed by the industry, could affect such plans, Schinecker said Roche would only say that the company was in discussions with the government. “These kinds of investments, you can only make if you can afford those investments. If you cut into that significantly, then the whole industry wouldn’t be able to invest these kinds of monies,” Schinecker said at the WSJ CEO Council.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1